Back to Search

Catumaxomab – Uses, Dosage, and Brands in UAE

Brand Name: REMOVAB
Strength: 10 mcg&50mcg | Form: Concentrate For Dilution For Infusion
Price in UAE: AED 83950.00
Available in UAE pharmacies

About Catumaxomab

Class: | Monoclonal antibody (bispecific T-cell engager) Use: | Treatment of malignant ascites in patients with epithelial ovarian cancer, gastric cancer, or other solid tumors. Adult dose: | 10 mcg administered as an intravenous infusion on day 1, followed by 50 mcg on days 2, 3, and 4, with a maximum of 4 treatment cycles. Pediatric dose: | Safety and efficacy have not been established in pediatric patients; not recommended for use in this population. Side effects: | Common side effect

Drug Class

Monoclonal antibody (bispecific T-cell engager)

Uses & Indications

Treatment of malignant ascites in patients with epithelial ovarian cancer, gastric cancer, or other solid tumors.

Storage Requirements

Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.

Manufacturer & Packaging

Manufacturer: Fresenius Biotech GmbH, GERMANY

Package Size

Pack of 3 x 10mcg Pre-Filled Syring & 4 x 50mcg Pre-Filled Syring

Price & Supplier

Price in UAE: AED 83950.00

Dosage Information

Adult Dose

10 mcg administered as an intravenous infusion on day 1, followed by 50 mcg on days 2, 3, and 4, with a maximum of 4 treatment cycles.

Pediatric Dose

Safety and efficacy have not been established in pediatric patients; not recommended for use in this population.

Side Effects

Common side effects include fever, chills, nausea, vomiting, abdominal pain, fatigue, and infusion-related reactions.

Contraindications & Precautions

Hypersensitivity to catumaxomab or any component of the formulation; patients with severe liver impairment.

Important Warnings

Risk of severe infusion-related reactions; monitor patients closely during infusion. Potential for cytokine release syndrome; premedication may be required.

Related Medicines in Same Category

See also: Other Monoclonal antibody (bispecific T-cell engager) medicines available in UAE pharmacies

Blinatumomab Glofitamab Glofitamab Talquetamab Teclistamab Teclistamab

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Monoclonal antibody (bispecific T-cell engager) Medicines Browse All Categories